Double-perovskite magnetic La2NiMnO6 nanoparticles for adsorption of bovine serum albumin applications

  • Zhi-Yong Wu1,

    Affiliated with

    • Cai-Bin Ma2,

      Affiliated with

      • Xin-Gui Tang2Email author,

        Affiliated with

        • Rui Li2,

          Affiliated with

          • Qiu-Xiang Liu2 and

            Affiliated with

            • Bao-Tian Chen1Email author

              Affiliated with

              Nanoscale Research Letters20138:207

              DOI: 10.1186/1556-276X-8-207

              Received: 13 March 2013

              Accepted: 20 April 2013

              Published: 2 May 2013


              Double-perovskite La2NiMnO6 (LNMO) nanoparticles were synthesized by co-precipitation process, and the adsorption of bovine serum albumin (BSA) protein on these nanoparticles was carried out. The powder samples were annealed at 750, 850, 950, and 1,050°C, respectively. X-ray diffraction (XRD) results reveal that there are double perovskites and exhibit mixed orientations, without any impurity phases. Transmission electron microscopy results as well as the XRD estimate results show that the crystalline size is about 34 to 40 nm. The adsorption of BSA on the magnetic nanoparticles was analyzed using a UV spectrophotometer at room temperature. The results show that the as-prepared LNMO nanoparticles display a good adsorbing ability for BSA, and the nanoparticle sintered at 850°C has the highest value of 219.6 mg/g, which is much higher than others.


              Chemical co-precipitation LNMO Magnetic property Nanoparticles Adsorption Bovine serum albumin protein


              Magnetic nanoparticles are commercially important materials as a consequence of their stability and striking magnetic property [1] and are applied widely in biological and medical areas, such as bioseparation [2], drug and gene delivery [3], quantitative immunoassay [4], and hyperthermia [5].

              Recently, magnetic nanoparticles, such as CoFe2O4, MnFe2O4, Fe2O3, Fe3O4, and Fe [610], have been studied mostly for biomedical applications, but the application of double-perovskite La2NiMnO6 nanoparticles in biomedical has not been reported. Double-perovskite La2NiMnO6 is a ferromagnetic material and attractive due to its impressive properties. In order to be applied in biological and medical fields, La2NiMnO6 nanoparticles should be monodispersed to bind biomolecules. Proteins are relatively large biomolecules and usually have a tendency to accumulate at the interface between aqueous solutions and solid surfaces [1115]. Protein adsorption to surfaces is important in many disciplines, including biomedical engineering, biotechnology, and environmental science.

              Many works were used to research the magnetic characteristics of double-perovskite nanoparticles. There has been no report about the application of these nanoparticles in biomedicine. Our experiments show that different annealing temperatures can affect the adsorbing ability for bovine serum albumin (BSA). In this paper, we report that the monodispersed La2NiMnO6 nanoparticles were synthesized by co-precipitation, and the magnetic properties and adsorption characteristics of bovine serum albumin for these nanoparticles were analyzed.


              The La2NiMnO6 (LNMO) nanocomposites were synthesized by co-precipitation, using La(NO3)3·5H2O(99.5%), Ni(CH3COO)2·4H2O (98%), and Mn(CH3COO)4·4H2O(99%) as starting raw materials [16]. The raw powders were dissolved in deionized water in required stoichiometric proportions. The solutions were then poured together into a beaker and stirred in a magnetic blender at 80°C. After 2 h, aqueous ammonia solution was added to the container until a brown suspension took shape at a pH of approximately 8.5 [17]. After stirring for about 30 min, the suspension was ball-milled for 24 h with ethanol as a milling medium in order to mix the reactants well enough and then dried in a cabinet dryer at 80°C overnight to obtain the precursor samples. The dried powders were finally annealed in nitrogen atmosphere for 2 h at different temperatures in the range of 750°C~1,050°C.

              The crystalline phase of LNMO nanocomposites was identified using the X-ray diffraction (XRD) technique. The X-ray diffractogram of all the samples from 10° to 70° at a scanning step of 0.02°/s was recorded using a Rigaku X-ray diffractometer (Rigaku Corporation, Tokyo, Japan) with Cu Kα radiation (λ = 1.54056 Ǻ ). The magnetic properties were measured using a vibrating sample magnetometer (PPMS-9, Quantum Design, Inc., San Diego, CA, USA) at room temperature under a maximum field of 30 kOe. The structural defects in the LNMO materials were investigated using a JEOL 4000EX high-resolution transmission electron microscope (HRTEM; JEOL Ltd., Tokyo, Japan) operated at 400 kV. The adsorption of BSA protein on nanoparticles was analyzed with a UV spectrophotometer (UV-2401 PC, Shimadzu Corporation, Kyoto, Japan) at room temperature. The aqueous solution with a pH of about 7.4 contained 1.000 mg/ml BSA (purity >99%) before the adsorption, and for each measurement, 3.00 to 12.00 mg of La(Ni0.5Mn0.5)O3 nanoparticles was used as the adsorbent. The adsorbent was stirred ultrasonically in the BSA solution for 1 h at room temperature, which was put in static precipitation condition after 12 h to be measured.

              Results and discussion

              Figure 1 presents the XRD patterns for the whole samples with temperatures ranging from 750°C to 1,050°C. All of the diffraction peaks are identified and indexed according to the standard diffraction pattern data of LNMO powders. As seen from the scan (Figure 1), the LNMO nanoparticles have formed a pure perovskite and exhibit random orientation [18, 19]. The lattice constants of LNMO are a = 5.467 Ǻ, b = 5.510 Ǻ, c = 7.751 Ǻ, and β = 91.12°. It is also observed that the diffraction peaks become narrower and sharper with the increase of annealing temperature, indicating an augmentation of the crystallite size, which has been confirmed by the crystallite size calculation using the Scherrer formula at (100) and (200) peaks:
              D = 0.9 λ β cos θ ,
              where D is the crystallite size, λ is the wavelength of Cu Kα, β is the full width at half maximum of the diffraction peaks, and θ is the Bragg angle. The calculated crystallite sizes are shown in Table 1. As the annealing temperature increases from 750°C to 1,050°C, the grain sizes of the nanocrystallites increase from 33.9 to 39.6 nm.
              Table 1

              Average grain size and magnetic and BSA adsorption properties of La(Ni 0.5 Mn 0.5 )O 3 nanoparticles

              Annealing temperature (°C)

              Grain size (nm)



              Nanoparticle mass (mg)

              BSA adsorbed (mg/g)





































              The nanoparticles were annealed at different temperatures for 2 h.

              Figure 1

              XRD patterns of LNMO nanoparticles annealed at different temperatures for 2 h. (a) 750°C, (b) 850°C, (c) 950°C, and (d) 1,050°C.

              LaMnO3 is an ABO3 perovskite ferromagnetic material. The ionic radius of Ni3+ (62 pm) is smaller than that of Mn3+ (66 pm). Therefore, an inhomogeneous distribution results at the B site of the structure. A cationic disorder induced by B-site substitution is always regarded as the main derivation of crystalline growth. On the other hand, LaNiO3 is a paramagnetic material; the La ion locates at the central equilibrium position of the LaNiO3 lattice. In this case, the macrodomain in LaMnO3 could be divided into the microdomains which probably cause the crystalline growth. Because the domain size relates to the grain sizes, the grain size increases slowly when the annealing temperature increases.

              Figure 2 shows the TEM morphology of the obtained LNMO nanoparticles. It can be observed from the TEM morphology and XRD analysis that the LNMO nanoparticles form a group of cluster phenomenon and that the average grain size is about 40 nm.
              Figure 2

              The HRTEM morphology of the LNMO sample annealing at 750°C for 2 h.

              The magnetic hysteresis loops of the samples annealed at 750°C, 850°C, 950°C, and 1,050°C are shown in Figure 3. It is seen that the whole magnetization curves are not saturated at a maximum external field of 30 kOe and that the hysteresis curves for all samples are ‘S’ shaped with very low coercivity (HC < 45 Oe); both of which are characteristics of the superparamagnetism as reported in [1820]. Superparamagnetic particles could be fit to a simple Langevin theory M(H)/M S = L(x), where M(H) is the magnetization for an applied field H, and MS represents the saturation magnetization. Thus, by applying the curves to the Langevin formula, we should be able to approximately determine MS[20, 21]. In the Langevin function, L(x) = coth x − 1/x, where x = μH/k B T, μ is the uncompensated magnetic moment, k B stands for Boltzmann’s constant, and T represents the absolute temperature. For high fields, it gives 1 − k B T/μH for the form of the approach to saturation. Consequently, we may come to a conclusion: M(H) = M S (1 − a/H), where the term α is used to replace some constants mentioned above in order to simplify the formula.
              Figure 3

              Field-dependent magnetization hysteresis of LNMO samples annealing at various temperatures.

              The UV spectra of BSA at 280 nm were recorded to investigate the BSA binding capacity of the LNMO nanoadsorbents; 1-mg nanoadsorbents’ adsorptive capacity of BSA is calculated by Equation 2 [22]:
              η = m BSA A BSA A mag m mag A BSA ,

              where η indicates the amount of 1-mg nanoadsorbents (mg/g) in the adsorbed BSA, mBSA is the total weight of BSA (mg), mmag is the dry weight of nanopowders used to bind BSA (mg), ABSA points to the UV absorbance value of the blank BSA solution, and Amag refers to the UV absorbance value of the supernatant after adsorption.

              Adsorption of bovine serum albumin on LNMO nanoparticles

              BSA is a globular protein with the approximate shape of a prolate spheroid with dimensions of 4 nm × 4 nm × 14 nm [23]. Table 1 shows BSA adsorption on the LNMO nanoparticles. From Table 1, it can be seen that the LNMO nanoparticles exhibit a good absorbing characteristic for BSA protein. The BSA adsorption capability on the LNMO nanoparticles is influenced possibly by their grain size, specific surface area, magnetic properties, interface structure, the electrostatic attraction between BSA and magnetic nanoparticles, etc., which are related to the preparation process. The LNMO nanoparticles annealed at 850°C show the highest BSA adsorption at around 219.6 mg/g. On this circumstance, the volume of the aqueous BSA solution after adsorption was increased to about 3 ml. The LNMO nanoparticles annealed at 850°C showed the lowest coercive field (19.9 Oe, see Table 1) and have the highest BSA adsorption at around 219.6 mg/g; the main reason is based on the critical grain size of LNMO nanoparticles for BSA adsorption.

              The reason for this is not clear, and it needs a further systematic study. In fact, up to now, protein adsorption mechanism on nanoparticles is not fully understood although it has been intensively investigated by researchers [24, 25].


              In conclusion, La(Ni0.5Mn0.5)O3 (LNMO) nanoparticles have been successfully prepared using the chemical co-precipitation process. The grain size and magnetic properties of the LNMO nanoparticles are largely influenced by annealing temperature. As the annealing temperature increases from 750°C to 1,050°C, the average grain size increases from about 33.9 to 39.6 nm, respectively. The saturation magnetization increases from about 35.95 to 67.19 emu/g; However, as the annealing temperature increases from 950°C to 1,050°C, the average grain size decreases from about 37.9 to 39.6 nm, and the saturation magnetization decreases from about 1.97×10-3 to 3.79×10-3 emu/g. On the other hand, the coercivity initially increases, reaching a maximum value of 42.3 Oe when the average grain size is about 37.9 nm at 950°C, and then reduces. The LNMO nanoparticles showed good adsorption performance in bovine serum albumin protein, and the preliminary optimized adsorption is obtained for the LNMO nanoparticles annealed at 850°C. These LNMO nanoparticles are a potential carrier for large biomolecules, which will be widely used in the biomedical field.



              This work was supported by the National Natural Science Foundation of China (grant nos. 10774030 and 11032010), the Guangdong Provincial Natural Science Foundation of China (Grant Nos. 8151009001000003 and 10151009001000050), and the Guangdong Provincial Educational Commission of China (No. 2012KJCX0044).

              Authors’ Affiliations

              Department of Traditional Chinese Medicine of Nanfang Hospital, Southern Medical University
              School of Physics and Optoelectric Engineering, Guangzhou Higher Education Mega Center, Guangdong University of Technology


              1. Eerenstein W, Mathur ND, Scott JF: Multiferroic and magnetoelectric materials. Nature 2006, 442(7104):759–765. 10.1038/nature05023View Article
              2. Ito A, Shinkai M, Honda H, Kobayashi T: Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 2005, 100(1):1–11. 10.1263/jbb.100.1View Article
              3. McBain SC, Yiu HHP, Dobson J: Magnetic nanoparticles for gene and drug delivery. Int J Nanomed 2008, 3(2):169–180.
              4. Tang DP, Yuan R, Chai YQ: Magnetic core-shell Fe3O4@Ag nanoparticles coated carbon paste interface for studies of carcinoembryonic antigen in clinical immunoassay. J Phys Chem B 2006, 110(24):11640–11646. 10.1021/jp060950sView Article
              5. Banerjee R, Katsenovich Y, Lagos L: Nanomedicine: magnetic nanoparticles and their biomedical applications. Curr Med Chem 2010, 17(27):3120–3141. 10.2174/092986710791959765View Article
              6. Tang IM, Krishnamra N, Charoenphandhu N, Hoonsawat R, Pon-On W: Biomagnetic of apatite-coated cobalt ferrite: a core-shell particle for protein adsorption and pH-controlled release. Nanoscale Res Lett 2011, 6(1):19.View Article
              7. Mornet S, Vasseur S, Grasset F, Veverka P, Goglio G, Demourgues A, Portier J, Pollert E, Duguet E: Magnetic nanoparticle design for medical applications. Prog Solid State Chem 2006, 34(2–4):237–247.View Article
              8. Fan HM, Yi JB, Yang Y: Single-crystalline MFe2O4 nanotubes/nanorings synthesized by thermal transformation process for biological applications. ACS Nano 2009, 3(9):2798–2808. 10.1021/nn9006797View Article
              9. Kim HJ, Ahn JE, Haam S: Synthesis and characterization of mesoporous Fe/SiO2 for magnetic drug targeting. J Mater Chem 2006, 16(17):1617–1621. 10.1039/b514433gView Article
              10. Ruan J, Ji JJ, Song H, Qian QR, Wang K, Wang C, Cui DX: Fluorescent magnetic nanoparticle-labeled mesenchymal stem cells for targeted imaging and hyperthermia therapy of in vivo gastric cancer. Nanoscale Res Lett 2012, 7(1):309. 10.1186/1556-276X-7-309View Article
              11. Kopac T, Bozgeyik K, Yener J: Effect of pH and temperature on the adsorption of bovine serum albumin onto titanium dioxide. Colloids Surf A: Physicochem Eng Aspects 2008, 322(1–3):19–28.View Article
              12. Rezwan K, Meier LP, Gauckler LJ: Lysozyme and bovine serum albumin adsorption on uncoated silica and AlOOH-coated silica particles: the influence of positively and negatively charged oxide surface coatings. Biomater 2005, 26(21):4351–4357. 10.1016/j.biomaterials.2004.11.017View Article
              13. Rezwan K, Studart AR, Voros J: Change of xi potential of biocompatible colloidal oxide particles upon adsorption of bovine serum albumin and lysozyme. J Phys Chem B 2005, 109(30):14469–14474. 10.1021/jp050528wView Article
              14. Seitz R, Brings R, Geiger R: Protein adsorption on solid–liquid interfaces monitored by laser-ellipsometry. Appl Surf Sci 2005, 252(1):154–157. 10.1016/j.apsusc.2005.02.012View Article
              15. Hollmann O, Czeslik C: Characterization of a planar poly(acrylic acid) brush as a materials coating for controlled protein immobilization. Langmuir 2006, 22(7):3300–3305. 10.1021/la053110yView Article
              16. Chen DG, Tang XG, Wu JB, Zhang W, Liu QX, Jiang YP: Effect of grain size on the magnetic properties of superparamagnetic Ni0.5Zn0.5Fe2O4 nanoparticles by co-precipitation process. J Magn Magn Mater 2011, 232(12):1717–1721.View Article
              17. Li X, Li Q, Xia ZG, Yan WX: Effects on direct synthesis of large scale mono-disperse Ni0.5Zn0.5Fe2O4 nanosized particles. J Alloys Compd 2008, 458(1–2):558–563.View Article
              18. Chen DG, Tang XG, Tong JJ, Wu JB, Jiang YP, Liu QX: Dielectric relaxation of Ni0.5Zn0.5Fe2O4 ceramics. Solid State Commun 2011, 151(14–15):1042–1044.View Article
              19. Bo XX, Li GS, Qiu XQ, Xue YF, Li LP: Magnetic diphase nanostructure of ZnFe2O4/gamma-Fe2O3. J Solid State Chem 2007, 180(3):1038–1044. 10.1016/j.jssc.2006.12.034View Article
              20. Khadar MA, Biju V, Inoue A: Effect of finite size on the magnetization behavior of nanostructured nickel oxide. Mater Res Bull 2003, 38(8):1341–1349. 10.1016/S0025-5408(03)00139-9View Article
              21. Bean CP, Livingston JD: Superparamagnetism. J Appl Phys 1959, 30(4):120S-129S. 10.1063/1.2185850View Article
              22. Klajnert B, Stanislawska L, Bryszewska M, Palecz B: Interactions between PAMAM dendrimers and bovine serum albumin. BBA-Proteins Proteom 2003, 1648(1–2):115–126.View Article
              23. McClellan SJ, Franses EI: Effect of concentration and denaturation on adsorption and surface tension of bovine serum albumin. Colloids Surf B Biointerfaces 2003, 28(1):63–75. 10.1016/S0927-7765(02)00131-5View Article
              24. Peng ZG, Hidajat K, Uddin MS: Adsorption of bovine serum albumin on nanosized magnetic particles. J Colloid Interface Sci 2004, 271(2):277–283. 10.1016/j.jcis.2003.12.022View Article
              25. Liang HF, Wang ZC: Adsorption of bovine serum albumin on functionalized silica-coated magnetic MnFe2O4 nanoparticles. Mater Chem Phys 2010, 124(2–3):964–969.View Article


              © Wu et al.; licensee Springer. 2013

              This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.